U01.15.006 Neonatal abstinence syndrome

Learning Objectives

Master the clinical recognition of Neonatal Abstinence Syndrome (NAS). Understand the multi-system involvement (CNS, ANS, GI) and the specific pharmacological management for opioid-induced withdrawal in the neonate for the USMLE Step 1.


1. Pathogenesis and Etiology

NAS is a complex withdrawal disorder occurring in newborns exposed to addictive substances in utero. While various substances can cause NAS, it is most commonly associated with maternal opioid use (e.g., heroin, oxycodone, methadone).

System Clinical Presentation
CNS Irritability, high-pitched crying, tremors, and seizures.
Autonomic (ANS) Tachypnea, sneezing, yawning, and sweating.
Gastrointestinal Diarrhea and uncoordinated sucking reflexes (feeding difficulties).

2. Screening and Management

Early identification is critical. Universal screening for substance use is recommended for all pregnant patients to anticipate neonatal needs.

Intervention Strategy & Medications
Non-Pharm Swaddling, a low-stimulation environment, and frequent small feedings.
Pharmacotherapy Methadone, Morphine, or Buprenorphine (used for opioid withdrawal).

3. Differential: NAS vs. FAS

It is vital to distinguish between withdrawal (NAS) and structural teratogenicity (FAS).

Feature NAS (Withdrawal) FAS (Teratogenicity)
Primary Cause Opioids (most common). Alcohol.
Main Presentation Acute irritability & Sneezing. Facial dysmorphism & Microcephaly.

Activity:


High-Yield Clinical Pearls:

  • The High-Pitched Cry: This is a classic board clue for NAS. If the baby is sneezing and crying inconsolably, check for maternal opioid history.
  • Non-Opioid NAS: Remember that while opioids are most common, withdrawal from cocaine or amphetamines presents with similar CNS irritability but usually without the severe GI distress.
  • Suction Reflex: The “uncoordinated sucking” leads to poor weight gain in the first few days of life for these infants.

Activity: